BidaskClub upgraded shares of HMS (NASDAQ:HMSY) from a hold rating to a buy rating in a research note issued to investors on Thursday morning.

Several other brokerages also recently commented on HMSY. Zacks Investment Research raised HMS from a hold rating to a buy rating and set a $32.00 target price for the company in a research note on Wednesday, January 16th. First Analysis upgraded HMS from a neutral rating to an outperform rating and boosted their price target for the stock from $31.00 to $38.00 in a report on Sunday, November 4th. Cantor Fitzgerald boosted their price target on HMS to $31.00 and gave the stock a neutral rating in a report on Monday, November 5th. Finally, ValuEngine cut HMS from a strong-buy rating to a buy rating in a report on Monday, December 17th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of Buy and an average price target of $33.10.

Shares of NASDAQ HMSY opened at $30.63 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 4.04 and a quick ratio of 4.04. The stock has a market cap of $2.57 billion, a price-to-earnings ratio of 71.23, a price-to-earnings-growth ratio of 2.93 and a beta of 1.50. HMS has a 12 month low of $14.88 and a 12 month high of $38.15.

In related news, Director William F. Miller III sold 5,877 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $34.61, for a total value of $203,402.97. Following the sale, the director now directly owns 170,656 shares in the company, valued at $5,906,404.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William F. Miller III sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, December 6th. The shares were sold at an average price of $33.86, for a total value of $50,790.00. Following the completion of the sale, the director now owns 159,018 shares in the company, valued at $5,384,349.48. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,193,745 shares of company stock worth $41,545,016. Company insiders own 4.54% of the company’s stock.

A number of hedge funds have recently made changes to their positions in HMSY. Oregon Public Employees Retirement Fund bought a new stake in HMS in the fourth quarter valued at approximately $32,000. We Are One Seven LLC bought a new stake in HMS in the fourth quarter valued at approximately $84,000. First Quadrant L P CA bought a new stake in HMS in the third quarter valued at approximately $107,000. LS Investment Advisors LLC boosted its holdings in HMS by 80.0% in the fourth quarter. LS Investment Advisors LLC now owns 5,016 shares of the business services provider’s stock valued at $141,000 after acquiring an additional 2,230 shares during the last quarter. Finally, BlueMountain Capital Management LLC bought a new stake in HMS in the third quarter valued at approximately $146,000. Institutional investors and hedge funds own 93.74% of the company’s stock.

About HMS

HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.

See Also: Should You Consider an Index Fund?

Analyst Recommendations for HMS (NASDAQ:HMSY)

Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.